PepGen PEPG
NASDAQ PEPG
$3.11 -0.07 (-2.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

PepGen (PEPG) Profit After Tax (2021 - 2026)

PepGen (PEPG) posted Profit After Tax of -$17.8 million for Q1 2026, up 2.57% sequentially from -$18.3 million in Q4 2025, and up 40.95% YoY from -$12.7 million in Q1 2025.

Analysis

PepGen (PEPG) Profit After Tax (2021 - 2026) Analysis & Trends

PepGen has reported Profit After Tax for 6 years, with the latest figure at -$17.8 million in Q1 2026.

  • Quarterly Profit After Tax rose 40.95% year-over-year to -$17.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$77.2 million (up 24.39% YoY) and the FY2025 annual result came in at -$89.7 million, changed 0.36% from the prior year.
  • Profit After Tax rose to -$17.8 million in Q1 2026 per PEPG's latest filing, from -$18.3 million in the prior quarter.
  • Over five years, Profit After Tax peaked at -$14.9 million in Q4 2022 and troughed at -$30.2 million in Q1 2025.
  • A 5-year average of -$20.3 million and a median of -$18.6 million in 2022 frame the typical range for Profit After Tax.
  • The sharpest annual moves came in 2022 and 2026: Profit After Tax slumped 221.3% in 2022, then jumped 40.95% in 2026.
  • Over 5 years, Profit After Tax stood at -$14.9 million in 2022, then retreated by 29.91% to -$19.4 million in 2023, then fell by 14.68% to -$22.3 million in 2024, then grew by 17.75% to -$18.3 million in 2025, then gained by 2.57% to -$17.8 million in 2026.
  • According to Business Quant data, Profit After Tax over the past three periods registered -$17.8 million, -$18.3 million, and -$18.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -782.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -644.37 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 237.01 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 164.49 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 81.49 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -16.62 Mn
10 PepGen 217.99 Mn 217.99 Mn - -17.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -17.87 Mn
Mar 31, 2026 -17.76 Mn
Dec 31, 2025 -18.30 Mn
Sep 30, 2025 -18.03 Mn
Jun 30, 2025 -23.11 Mn
Mar 31, 2025 -30.20 Mn
Dec 31, 2024 -22.25 Mn
Sep 30, 2024 -21.38 Mn
Jun 30, 2024 -28.34 Mn
Mar 31, 2024 -18.02 Mn
Dec 31, 2023 -19.50 Mn
Sep 30, 2023 -23.36 Mn
Jun 30, 2023 -19.52 Mn
Mar 31, 2023 -16.32 Mn
Dec 31, 2022 -14.94 Mn
Sep 30, 2022 -18.61 Mn
Jun 30, 2022 -17.32 Mn
Mar 31, 2022 -18.25 Mn
Dec 31, 2021 -7.14 Mn
Sep 30, 2021 -8.11 Mn